# Avation Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avation-medical

- Industry: Medical Devices & Equipment
- Headquarters: Columbus, US
- Website: www.avation.com
- Total disclosed funding: $22M
- Latest round: Series C (Feb 1, 2024)
- Investors on record: 8

## About

Based in Ohio, US, and founded by Jill Schiaparelli (CEO), Avation Medical, Inc. operates as a healthcare platform that engages in developing a therapeutic device for patients suffering from urinary urgency and urinary incontinence. In March 2026, Avation Medical, Inc. raised an undisclosed amount in series D funding.


The firm develops and offers its non-invasive neuromodulation treatment through its flagship product, the Vivally® System, which is a smart wearable bladder control therapy and mobile app designed for individuals with urinary issues. The platform offers a drug-free therapy that combines neuromodulation technology with a digital behavioral support app, providing personalized treatment for patients.

## Funding rounds

- Series C, Feb 1, 2024, $22M — Arboretum Ventures, Medtronic, ShangBay Capital, Tonkawa, Avestria Ventures, Asahi Kasei Corporate Venture Capital, Angelini Ventures, JobsOhio Growth Capital Fund

## Investors

- Arboretum Ventures (https://capitalatlas.ai/funds/arboretum-ventures) — Series C
- Medtronic — Series C
- ShangBay Capital (https://capitalatlas.ai/funds/shangbay-capital) — Series C
- Tonkawa — Series C
- Avestria Ventures (https://capitalatlas.ai/funds/avestria-ventures) — Series C
- Asahi Kasei Corporate Venture Capital — Series C
- Angelini Ventures (https://capitalatlas.ai/funds/angelini-ventures) — Series C
- JobsOhio Growth Capital Fund — Series C